Trial Profile
Phase-II, Randomized, Multicentre Pilot Study to Evaluate the Safety and Efficacy of the Treatment With mFOLFOX-6 Plus Cetuximab Versus Initial Treatment With mFOLFOX-6 Plus Cetuximab (for 8 Cycles), Followed by Maintenance With Cetuximab Alone as First-line Treatment in Patients With Metastatic Colorectal Cancer (mCRC) and Wild-type KRAS Tumours
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Jul 2023
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms MACRO-2
- 19 Jun 2023 Results of pooled analysis data pooled analysis of Valentino, Panama, MACRO-2, COIN-B trials published in the European Journal of Cancer
- 24 Jul 2018 Primary endpoint has been met. (Progression-free survival) as per results published in the European Journal of Cancer
- 24 Jul 2018 Results published in the European Journal of Cancer